Pancreaticoduodenectomy with mesentericoportal vein resection for adenocarcinoma of the pancreatic head

World Journal of Surgery

Volumn 30, Issue 8, 2006, Pages 1526-1535

  Carrère, Nicolas ^a   Sauvanet, Alain ^a   Goere, Diane ^a   Kianmanesh, Reza ^a   Vullierme, Marie Pierre ^a   Couvelard, Anne ^a   Ruszniewski, Philippe ^a   Belghiti, Jacques ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANESTHESIST; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE FREE SURVIVAL; FEMALE; HISTOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; LOG RANK TEST; MALE; MEDICAL SOCIETY; MORBIDITY; MULTIVARIATE ANALYSIS; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; SURGICAL TECHNIQUE; UNIVARIATE ANALYSIS;

ADENOCARCINOMA; COMMON BILE DUCT NEOPLASMS; FEMALE; HUMANS; MALE; MESENTERIC VEINS; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PORTAL VEIN; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 33748858695     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-005-0784-4     Document Type: Conference Paper

References (33)

1. Warshaw AL, Fernandez-del Castillo C. Pancreatic carcinoma. N Engl J Med 1992;326:455-465.
2. Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 1997;226:248-257.
3. Fernandez-del Castillo C, Rattner DW, Warshaw AL. Standards for pancreatic resection in the 1990s. Arch Surg 1995;130:295-299.
4. Neoptolemos JP, Russell RC, Bramhall S, et al. Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units. UK Pancreatic Cancer Group. Br J Surg 1997;84:1370-1376.
5. Yeo CJ, Sohn TA, Cameron JL, et al. Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg 1998;227:821-831.
6. Bramhall SR, Allum WH, Jones AG, et al. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 1995;82:111-115.
7. Sener SF, Fremgen A, Menck HR, et al. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg 1999;189:1-7.
8. Harrison LE, Klimstra DS, Brennan MF. Isolated portal vein involvement in pancreatic adenocarcinoma. A contraindication for resection? Ann Surg 1996;224:342-347.
9. Fuhrman G, Leach S, Staley C, et al. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann Surg 1996;223:154-162.
10. Leach S, Lee J, Charnsangavej C, et al. Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg 1998;85:611-617.
11. Bachellier P, Nakano H, Oussoultzoglou P, et al. Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile? Am J Surg 2001;182:120-129.
12. Tseng JF, Raut CP, Lee JE, et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 2004;8:935-950.
13. Allema J, Reinders M, van Gulik T, et al. Portal vein resection in patients undergoing pancreatoduodenectomy for carcinoma of the pancreatic head. Br J Surg 1994;81:1642-1646.
14. Roder J, Stein H, Siewert J. Carcinoma of the periampullary region: who benefits from portal vein resection? Am J Surg 1996;171:170-174.
15. Launois B, Stasik C, Bardaxoglou E, et al. Who benefits from portal vein resection during pancreaticoduodenectomy for pancreatic cancer? World J Surg 1999;23:926-929.
16. van Geenen RC, ten Kate FJ, de Wit LT, et al. Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy. Surgery 2001;129:158-163.
17. Capussotti L, Massucco P, Ribero D, et al. Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy. Arch Surg 2003;138:1316-1322.
18. Miettinen OS. Individual matching with multiple controls in the case of all-or-none responses. Biometrics 1969;25:339-355.
19. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: part 2: randomized controlled trial evaluating survival, morbidity and mortality. Ann Surg 2002;236:355-368.
20. Pedrazzoli S, DiCarlo V, Dionigi R, et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 1998;228:508-517.
21. Varty PP, Yamamoto H, Farges O, et al. Early retropancreatic dissection during pancreaticoduodenectomy. Am J Surg 2005;189:488-491.
22. Munoz-Bongrand N, Sauvanet A, Denys A, et al. Conservative management of pancreatic fistula after pancreaticoduodenectomy with pancreaticogastrostomy. J Am Coll Surg 2004;199:198-203.
23. Hamilton SR, Aaltonen LA. (2000) Pathology and genetics of tumours of the digestive system IARC Press, Washington, DC.
24. (UICC) IUAC(2002) TNM: classification of malignant tumours6 Wiley, New York, NY.
25. Poon R, Fan S, Lo C, et al. Pancreaticoduodenectomy with en bloc portal vein resection for pancreatic carcinoma with suspected portal vein involvement. World J Surg 2004;28:602-608.
26. Andersen HB, Baden H, Brahe NE, Burcharth F. Pancreaticoduodenectomy for periampullary adenocarcinoma. J Am Coll Surg 1994;179:545-552.
27. Klinkenbijl JH, Jeekel J, Sahmoud T, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999;230:776-782.
28. Neoptolemos JP, Dunn JA, Stocken DD, et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 2001;358:1576-1585.
29. Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004;350:1200-1210.
30. Stojadinovic A, Brooks A, Hoos A, et al. An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma. J Am Coll Surg 2003;196:954-964.
31. Koniaris LG, Schoeniger LO, Kovach S, et al. The quick, notwist, no-kink portal confluence reconstruction. J Am Coll Surg 2003;196:490-494.
32. Clavien P, Rudiger H. A simple technique of portal vein resection and reconstruction during pancreaticoduodenectomy. J Am Coll Surg 1999;189:629-634.
33. Howard TJ, Villanustre N, Moore SA, et al. Efficacy of venous reconstruction in patients with adenocarcinoma of the pancreatic head. J Gastrointest Surg 2003;7:1089-1095.